The effect of the IL-6 monoclonal blocker on the course of aseptic femoral head necrosis in the experiment (pilot study)

Background There is currently no pathogenetically based treatment for aseptic necrosis of the femoral head. One of the most promising areas of possible targeted therapy is the use of genetically engineered drugs, including monoclonal blockers of proinflammatory cytokines, aimed at inhibiting infla...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Nikita A. Shabaldin, Anna V. Sinitskaya, Lyudmila N. Igisheva, Lev A. Bogdanov, Andrey V. Shabaldin
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics 2024-06-01
Sarja:	Гений oртопедии
Aiheet:	aseptic necrosis genetically engineered drugs osteodestruction il-6 monoclonal blocker osteoblastogenesis osteoclastogenesis osteoinduction anti-inflammatory therapy
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!